The company said the results of a planned interim analysis met prespecified criteria for early termination of the study. "They did not meet the high-bar efficacy we established for advancing our ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study ...

The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...

Gadgets are now a part of the everyday routine for us. Tablets, phones, and laptops not only tend to affect the posture and ...

Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...

A recent study revealed that iron deficiency without anemia is common among adults with moderate-to-severe atopic dermatitis ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

If you’re struggling with dry skin this winter, we know it can feel like an uphill battle to keep your skin moisturized. Throw dermatitis into the mix, and the frustration compounds. No one wants to ...

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, ...

Perioral dermatitis can be a frustrating condition and it can return without proper treatment. You may try prescription antibiotics or lifestyle changes. It can take weeks or months for the condition ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...